← Open Payments lookup

ISABEL MUNOZ: Open Payments

NPI 1427218809 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$767 in 34 payments from 14 companies in 2025. Trend: 2023 $353 · 2024 $812 · 2025 $767

Food & beverage: $767
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$122
SANOFI-AVENTIS U.S. LLC5$112
Boehringer Ingelheim Pharmaceuticals, Inc.5$101
Exact Sciences Corporation2$68
AstraZeneca Pharmaceuticals LP4$64
Novo Nordisk Inc3$54
Amgen Inc.3$44
RGH Enterprises LLC2$41
Bayer Healthcare Pharmaceuticals Inc.2$38
ACADIA Pharmaceuticals Inc2$37

Products named: XIFAXAN, TZIELD, JARDIANCE, Cologuard Collection Kit, BREZTRI, Rybelsus, Kerendia, DAYBUE.

Industry payments across TX — which companies pay providers there.